Hormone therapies, known
as androgen deprivation therapies, help arrest the disease by reducing a patient's androgen levels.
Not exact matches
Enzalutamide, which is taken
as four pills once per day, is already approved by the Food and Drug Administration (FDA) for men whose disease has not been stopped by other treatments including, surgery, radiation,
androgen deprivation therapy and chemotherapy.
Androgen deprivation therapy is a powerful tool against prostate cancer, and more and more men are opting for the treatment
as a growing array of hormone - based therapies become available.
A second phase 3 study presented Sunday found that adding radiation to hormone therapy, also known
as androgen -
deprivation therapy (ADT) in patients with locally advanced or high - risk prostate cancer reduced the seven - year risk of dying by 43 percent compared to treating with hormone therapy alone.
Common conventional treatment is
androgen deprivation therapy (ADT), which drastically reduces testosterone levels resulting in many distressing side effects, such
as sexual dysfunction.